Treatment and Prevention of Caprine Mastitis: Evidence-Based Strategies for Better Herd Health

Mastitis remains one of the most important health challenges affecting dairy goat production due to its impact on milk yield, milk quality, animal welfare, and farm profitability. Effective management requires more than treating individual cases; it involves timely diagnosis, appropriate therapeutic decisions, antimicrobial stewardship, and consistent preventive practices at the herd level. 

For veterinarians managing goat farms, treatment strategies should be guided by the type of mastitis, severity of infection, causative organism, and available diagnostic information. At the same time, prevention remains a critical component because reducing new infections is essential for maintaining long-term udder health and minimizing economic losses. 

Importance of Early Diagnosis Before Treatment 

Successful mastitis management begins with early recognition and appropriate diagnostic evaluation. Clinical mastitis can often be identified through visible udder inflammation, abnormal milk appearance, pain, and systemic signs such as fever or reduced feed intake^1,2. However, subclinical mastitis requires diagnostic support because affected goats may not show obvious changes. 

Routine mastitis monitoring, combined with appropriate diagnostic methods, helps identify infected animals before infections become severe. Identifying the causative pathogen and assessing antimicrobial susceptibility are important steps for selecting appropriate treatment options and supporting responsible antimicrobial use. 

Therapeutic Approaches in Goat Mastitis 

Antimicrobial therapy is commonly used in mastitis management; however, treatment decisions should consider infection characteristics and the individual case. Dry-period therapy is considered a useful approach because it can reduce milk discard, control latent infections, and decrease the risk of antimicrobial residues and resistance when applied appropriately. 

Selective dry-period therapy based on the likelihood of intramammary infection at dry-off can provide a cost-effective approach to mastitis management. The dry period is an important stage because infections present during this period may contribute to mastitis during kidding and early lactation³. 

Different routes of antimicrobial administration may be considered depending on the infection. Parenteral administration provides higher drug availability in the body and may be beneficial for systemic infections or some local intramammary infections. Intramammary administration delivers high drug concentrations directly into the mammary gland and may be useful when local circulation is compromised. 

However, there is no evidence that a single treatment route is effective for every type of mastitis⁴. Therefore, treatment decisions should be based on clinical assessment, pathogen identification where possible, and antimicrobial resistance information. 

Importance of Antimicrobial Stewardship 

Unnecessary or inappropriate antimicrobial use can contribute to antimicrobial resistance (AMR), making future infections more difficult to manage. Pathogens involved in goat mastitis may develop resistance mechanisms, including biofilm formation, genetic changes, and reduced susceptibility to antimicrobial agents^5,6. 

Bacterial identification and antimicrobial susceptibility testing can support more targeted treatment decisions. Infections caused by minor pathogens generally show higher cure rates compared with infections caused by major pathogens⁷. Therefore, understanding the causative organism helps veterinarians avoid ineffective treatments and improve herd-level outcomes. 

Preventive Strategies for Mastitis Control 

Prevention of mastitis relies heavily on maintaining proper hygiene, reducing pathogen exposure, and protecting teat integrity. Key preventive practices include: 

• Maintaining clean udders before and after milking 

• Practicing proper hand hygiene during milking 

• Using teat dipping before and after milking 

• Keeping bedding areas clean and dry 

• Maintaining hygienic milking equipment 

• Reducing cross-contamination between animals 

• Monitoring and managing goats with recurrent infections 

Controlling infections among young goats is also important. Respiratory disease prevention through vaccination and temporary isolation can help reduce disease transmission within herds⁸. 

Management practices that may increase infection risk should be avoided. Excessive udder massage, machine stripping, and repeated teat cup attachment can compromise teat protection and contribute to infection spread⁸. 

Role of Veterinary Guidance in Herd-Level Control⁸ 

Veterinarians play an important role in designing mastitis control programs that consider farm conditions, animal health status, and management practices. Culling animals with repeated infections, improving milking procedures, and strengthening sanitation measures can contribute to reducing mastitis transmission. 

A successful prevention program requires collaboration between veterinarians and farmers because mastitis control depends on consistent implementation of management practices rather than isolated treatment interventions. 

Practical Clinical Insights 

• Treat mastitis cases based on diagnosis and clinical evaluation rather than routine antimicrobial administration. 

• Consider pathogen identification whenever possible to support appropriate antimicrobial selection. 

• Use dry-period management strategically to reduce future infection risk. 

• Focus on hygiene, teat protection, and herd monitoring to prevent new infections. 

Conclusion 

Effective control of caprine mastitis requires a balanced approach combining early diagnosis, appropriate treatment, antimicrobial stewardship, and preventive management. While therapeutic interventions remain important for affected goats, long-term improvement in herd health depends on reducing infection risks through better hygiene and farm management practices. Veterinarians can significantly influence mastitis outcomes by guiding farmers toward practical, sustainable, and evidence-based udder health strategies. 

References 

1. Yan Y, Zhu K, Liu H, Fan M, Zhao X, Pan M, Ma B, Wei Q. The relationship between mastitis and antimicrobial peptide S100A7 expression in dairy goats. Veterinary Sciences. 2023 Nov 14;10(11):653. https://www.mdpi.com/2306-7381/10/11/653 

2. Rana EA, Das T, Dutta A, Rahman M, Bostami MB, Akter N, Barua H. Coagulase-positive methicillin-resistant Staphylococcus aureus circulating in clinical mastitic goats in Bangladesh. Veterinary World. 2020 Jul 11;13(7):1303. https://pmc.ncbi.nlm.nih.gov/articles/PMC7429371/pdf/Vetworld-13-1303.pdf 

3. Ceniti C, Britti D, Santoro AM, Musarella R, Ciambrone L, Casalinuovo F, Costanzo N. Phenotypic antimicrobial resistance profile of isolates causing clinical mastitis in dairy animals. Italian journal of food safety. 2017 May 3;6(2):6612. https://pmc.ncbi.nlm.nih.gov/articles/PMC5505090/pdf/ijfs-6-2-6612.pdf 

4. Filor V, Seeger B, De Buhr N, von Köckritz-Blickwede M, Kietzmann M, Oltmanns H, Meißner J. Investigation of the pathophysiology of bacterial mastitis using precision-cut bovine udder slices. Journal of dairy science. 2022 Sep 1;105(9):7705-18. https://www.sciencedirect.com/science/article/pii/S0022030222004106 

5. Helgadóttir S, Pandit S, Mokkapati VR, Westerlund F, Apell P, Mijakovic I. Vitamin C pretreatment enhances the antibacterial effect of cold atmospheric plasma. Frontiers in cellular and infection microbiology. 2017 Feb 22;7:43. https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2017.00043/pdf 

6. Li XH, Lee JH. Antibiofilm agents: A new perspective for antimicrobial strategy. Journal of Microbiology. 2017 Oct;55(10):753-66. https://jmicrobiol.or.kr/upload/pdf/jm-55-10-753.pdf 

7. Yu ZN, Wang J, Ho H, Wang YT, Huang SN, Han RW. Prevalence and antimicrobial-resistance phenotypes and genotypes of Escherichia coli isolated from raw milk samples from mastitis cases in four regions of China. Journal of global antimicrobial resistance. 2020 Sep 1;22:94-101. https://www.sciencedirect.com/science/article/pii/S2213716519303303 

8. Tibebu A, Teshome Y, Tamrat H, Bahiru A. Mastitis in goat: A review of etiology, epidemiology, economic impact, and public health concerns. One Health. 2025 Dec 1;21:101131. https://www.sciencedirect.com/science/article/pii/S2352771425001673